A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the severity of sleep apnea, a disorder that causes breathing to be interrupted, among other measures in patients who had obesity and took the medication for a year. The study, published Friday in the New England Journal of Medicine, was conducted in two controlled trials involving adults with moderate-to-severe obstructive sleep apnea and obesity. The study found that tirzepatide reduced the apnea-hypopnea index, body weight, blood pressure and improved sleep, among other things. Patients
Hence then, the article about weight loss drug could help treat sleep apnea study was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Weight loss drug could help treat sleep apnea: Study )